StonvexLoading…
StonvexStonvexStonvexCore line items from NDLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-30 | Annual 2024 2024-12-31 | Annual 2024 2024-01-02 | Annual 2023 2023-01-03 |
|---|---|---|---|---|
Revenue | $495.09M | $493.27M | $503.40M | $509.48M |
Operating Income | $-31.59M | $-27.78M | $-5.03M | $-832.00K |
Net Income | $-42.57M | $-36.21M | $-9.86M | $-3.31M |
EPS (Diluted) | $-7.36 | $-6.37 | $-1.72 | $-0.07 |
Total Assets | $261.67M | $324.65M | $368.10M | $343.84M |
Total Liabilities | $306.98M | $330.23M | $340.94M | $305.48M |
Cash & Equivalents | $1.26M | $1.15M | $3.01M | $1.52M |
Free Cash Flow OCF − CapEx | $-5.11M | $-21.21M | $-24.55M | $-24.33M |
Shares Outstanding | 5.85M | 5.72M | 44.99M | 46.04M |